Summary
The product NPP 100 mg/ml, manufactured by Vulkan Pharmaceuticals, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number 3LX51M, was submitted by manufacturer vulkanpharma@proton.me and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Nandrolone Phenylpropionate, with a concentration of 99.47 mg/ml, which is 0.53% below the labeled claim of 100 mg/ml.
The testing process began on 29 October 2024, with the sample received on 5 November 2024, and analysis completed on 13 November 2024. The results confirm that the product closely matches the stated dosage. However, manufacturer-submitted samples must always be scrutinized for reliability, as optimal batches may be selectively tested. Independent third-party testing remains crucial for validating these findings across multiple batches. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Vulkan Pharmaceuticals
- Product Name: NPP 100 mg/ml
- Active Ingredient: Nandrolone Phenylpropionate
- Batch Number: 3LX51M
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #52525
- Testing Ordered: 29 October 2024
- Sample Received: 5 November 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Vulkan Pharmaceuticals (Manufacturer)
- Analysis Paid For By: Vulkan Pharmaceuticals (Manufacturer)
Testing Results
- Specification: 100 mg/ml (as stated on the label)
- Measured Concentration: 99.47 mg/ml
- Accuracy: 99.47% (0.53% below the label claim)
- Variance: -0.53%
Verification Details
- Verification URL: https://janoshik.com/tests/52525_XQCST71N7KD3
Evaluation of Manufacturer-Submitted Testing
This analysis confirms the accuracy of the tested product but raises considerations regarding its submission and funding by vulkanpharma@proton.me. Manufacturer often select the best batches for testing, which may not fully reflect product consistency for consumers. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, independent validation through third-party testing remains essential to ensure uniform quality across all batches.
Conclusion
The analysis confirms that NPP 100 mg/ml is accurately dosed, with a measured concentration of 99.47 mg/ml. This result reflects strong quality control for this batch but highlights the need for continued independent testing to maintain product consistency. This report is provided to support educational and harm reduction efforts, helping consumers make informed decisions about anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
